What is the significance of a 3.6 cm pulmonary artery dilation found on a computed tomography (CT) calcium score and what follow-up tests are recommended?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 15, 2025 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Evaluation and Management of 3.6 cm Pulmonary Artery Dilation Found on CT Calcium Score

A pulmonary artery diameter of 3.6 cm is significantly dilated and warrants further evaluation with echocardiography and possible right heart catheterization to assess for pulmonary hypertension. This finding represents an important incidental discovery that requires appropriate follow-up, as it may indicate underlying cardiovascular disease.

Significance of 3.6 cm Pulmonary Artery Dilation

Diagnostic Threshold and Accuracy

  • A main pulmonary artery diameter ≥3.0 cm, or equal in diameter to the ascending aorta, is considered dilated according to established guidelines 1
  • Normal reference values from the Framingham Heart Study indicate that the 90th percentile cutoff for pulmonary artery diameter is 29 mm in men and 27 mm in women 1
  • Your measurement of 3.6 cm significantly exceeds these thresholds, indicating true dilation

Clinical Implications

  • Pulmonary artery dilation strongly correlates with pulmonary hypertension
  • When the main pulmonary artery is larger than the adjacent ascending aorta, pulmonary hypertension is almost always present (positive predictive value of 96%) 1
  • While CT calcium scoring is not optimized for precise pulmonary artery measurements, a value of 3.6 cm is substantially above normal thresholds and is likely accurate enough to warrant concern

Recommended Follow-up Testing

Immediate Next Steps

  1. Transthoracic Echocardiography (TTE)

    • First-line follow-up test to evaluate pulmonary artery pressure, right ventricular function, and rule out cardiac causes of pulmonary hypertension 1
    • Echocardiography can confirm the pulmonary artery dilation and estimate pulmonary artery pressures 2
    • The pulmonary artery to ascending aorta ratio (PA:A) on echocardiography is a strong predictor for the presence and severity of pulmonary hypertension 2

  2. Dedicated CT Pulmonary Angiography or MR Angiography

    • Provides more accurate measurement of pulmonary artery dimensions
    • Can identify potential causes of pulmonary hypertension such as chronic thromboembolic disease 1
    • Helps evaluate for other radiographic signs of pulmonary hypertension, including:
      • Right ventricular enlargement
      • Straightening of the interventricular septum
      • Mosaic attenuation of lung parenchyma 1

  3. Right Heart Catheterization

    • Gold standard for diagnosing pulmonary hypertension
    • Should be performed if non-invasive testing suggests pulmonary hypertension
    • Provides definitive pressure measurements and hemodynamic data 1
    • A mean pulmonary artery pressure ≥25 mmHg confirms pulmonary hypertension 3

Clinical Considerations

Risk Assessment

  • Pulmonary artery dilation ≥48 mm carries a 7.5 times higher risk of unexpected death in patients with pulmonary hypertension 4
  • Even borderline pulmonary hypertension (mean PA pressure 21-24 mmHg) can cause significant pulmonary artery dilation 3
  • The degree of dilation may correlate with:
    • Duration of symptoms
    • Pulmonary vascular resistance
    • Mean pulmonary artery pressure 3

Potential Etiologies to Consider

  • Pulmonary arterial hypertension (Group 1 PH)
  • Left heart disease (Group 2 PH)
  • Chronic thromboembolic pulmonary hypertension (Group 4 PH)
  • Lung diseases and/or hypoxemia (Group 3 PH)
  • Congenital heart disease with systemic-to-pulmonary shunts 1

Important Caveats

  1. Measurement Technique Matters

    • CT calcium scoring is not optimized for pulmonary artery measurements
    • Dedicated cardiac CT or MRI provides more accurate measurements
    • Echocardiography may underestimate the true diameter compared to CT or MRI

  2. Clinical Context is Essential

    • Correlation with symptoms (dyspnea, fatigue, chest pain) is important
    • Presence of risk factors for pulmonary hypertension should be assessed
    • Some patients with dilated pulmonary arteries may be asymptomatic despite elevated pressures

  3. Avoid Delays in Evaluation

    • Pulmonary hypertension is often diagnosed late in its course
    • Early detection and treatment can significantly improve outcomes
    • A systematic approach to evaluation can help identify treatable causes

By following this structured approach to evaluation, you can determine the clinical significance of the 3.6 cm pulmonary artery dilation and identify any underlying pathology requiring treatment.

References

1
Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

What is the management plan for a 66-year-old male with moderate pulmonary hypertension, dilated ascending aorta, and tricuspid regurgitation?
What is the accuracy of an x-ray (x-radiation imaging) in determining pulmonary artery dilation?
What is the management approach for elevated Pulmonary Artery Diastolic Pressure (PAEDP) in an echocardiogram?
What is the upper limit of pulmonary artery diameter?
What is the interpretation and further evaluation needed for an 82-year-old male patient with Hypertension (HTN), status post Hemorrhoidectomy (HPB) due to Rectal Ulcer (RTU), presenting with Hematuria (30 red blood cells/ul) and Proteinuria (100 mg/dl), Hyperglycemia (105 mg/dl), Elevated Uric Acid (29 mg/dl), and Elevated Uremia (62.1 mg/dl), who is asymptomatic?
Does a coronary artery calcium (CAC) score involve a computed tomography (CT) scan?
What are the guidelines for managing Acute Respiratory Distress Syndrome (ARDS)?
How do I treat knots in muscle tissue?
What is the mechanism of action (MOA) of Midodrine (Midodrine hydrochloride)?
What are the considerations for using midodrine (a medication for orthostatic hypotension) in patients with End-Stage Renal Disease (ESRD) and cirrhosis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question